Tap to start →
Photo: Daniel Sone, National Cancer Institute / Unsplash
1 / 3
Cagrilintide is an investigational long-acting amylin analog from Novo Nordisk, given weekly, studied alone and paired with semaglutide as CagriSema.
2 / 3
Cagrilintide is built to act like amylin , a fullness hormone, but to last about a week instead of minutes.
3 / 3
Cagrilintide is the amylin half of a combination that may become the next weekly weight-loss shot.
Cagrilintide is an investigational long-acting amylin analog from Novo Nordisk, given weekly, studied alone and paired with semaglutide as CagriSema.
Tap below for the full page. Not medical advice; talk to your clinician about your care.